Internal Medicine, Hematology & Oncology · Weston, FL
NPI
1457323404
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
2950 Cleveland Clinic Blvd
Weston, FL, 33331
Phone (954) 659-5840
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
757 services
Medicare patients, 2024
219
Average age 76
Drug cost, 2024
$6.7M
1,685 prescriptions
Company payments, 2025
$1,722
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rafael A Arteta-Bulos was code 99214 (office e&m - established), 329 times for 138 patients. In total Rafael A Arteta-Bulos billed 757 services in 13 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 329 | 138 | $75.50 | $25K |
| 99215 Office E&M - Established | Facility | 118 | 66 | $116.34 | $14K |
| 99214 Office E&M - Established | Office | 90 | 52 | $102.74 | $9,247 |
| 99205 Office E&M - New | Facility | 53 | 53 | $148.35 | $7,862 |
| 99215 Office E&M - Established | Office | 42 | 20 | $146.27 | $6,143 |
| 99213 Office E&M - Established | Facility | 32 | 29 | $51.22 | $1,639 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 28 | 26 | $13.55 | $379 |
| 99213 Office E&M - Established | Office | 20 | 18 | $75.12 | $1,502 |
| 99205 Office E&M - New | Office | 16 | 16 | $184.29 | $2,949 |
By year: 2022 $1.2M for 38,076 services; 2023 $758K for 25,356 services; 2024 $71K for 757 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rafael A Arteta-Bulos prescribed most often to Medicare patients was Prednisone, with 244 prescriptions and refills. In total Rafael A Arteta-Bulos wrote 1,685 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 244 | 266 | 55 | $809 |
| Abiraterone Acetate Generic | 218 | 218 | 31 | $181K |
| Orgovyx Relugolix | 209 | 209 | 36 | $546K |
| Erleada Apalutamide | 127 | 127 | 19 | $1.6M |
| Xtandi Enzalutamide | 86 | 86 | 14 | $1.1M |
| Ondansetron Hcl Generic | 60 | 60 | 49 | $779 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 44 | 80 | 21 | $626 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 44 | 44 | 31 | $1,005 |
| Talzenna Talazoparib Tosylate | 41 | 41 | Under 11 | $643K |
| Morphine Sulfate Er Morphine Sulfate | 33 | 33 | 15 | $836 |
| Nubeqa Darolutamide | 28 | 28 | Under 11 | $366K |
| Cabometyx Cabozantinib S-Malate | 25 | 25 | Under 11 | $607K |
| Prochlorperazine Maleate Generic | 25 | 25 | 20 | $530 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 23 | 24 | Under 11 | $960 |
| Bicalutamide Generic | 23 | 39 | 16 | $523 |
Brand drugs: - claims; generic drugs: 1,027 claims; opioid claims: 138.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rafael A Arteta-Bulos $1,722 ($1,722 in general payments such as food, travel and fees) from 25 companies. The largest payer was Caris MPI, Inc. with $253.
| Company | Payments | Amount |
|---|---|---|
| Caris MPI, Inc. | 3 | $253 |
| GlaxoSmithKline, LLC. GSK | 7 | $235 |
| Merck Sharp & Dohme LLC MRK | 8 | $125 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $122 |
| Daiichi Sankyo Inc. 4568.T | 4 | $106 |
| Pfizer Inc. PFE | 5 | $97 |
| Servier Pharmaceuticals LLC | 3 | $93.76 |
| Eisai Inc. 4523.T | 5 | $80.18 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $68.63 |
| Abbvie Inc. ABBV | 2 | $60.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.